Page last updated: 2024-09-05

serrawettin w2 and prodigiosin

serrawettin w2 has been researched along with prodigiosin in 2 studies

Compound Research Comparison

Studies
(serrawettin w2)
Trials
(serrawettin w2)
Recent Studies (post-2010)
(serrawettin w2)
Studies
(prodigiosin)
Trials
(prodigiosin)
Recent Studies (post-2010) (prodigiosin)
10057473321

Protein Interaction Comparison

ProteinTaxonomyserrawettin w2 (IC50)prodigiosin (IC50)
Low molecular weight protein-tyrosine phosphatase AMycobacterium tuberculosis H37Rv8.8

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, F; Chen, T; Li, L; Li, Z; Liu, Y; Su, C; Sun, Y; Wen, X; Xiang, Z; Zhao, F; Zhao, X; Zhou, Y1
Clements, T; Khan, W; Ndlovu, T1

Other Studies

2 other study(ies) available for serrawettin w2 and prodigiosin

ArticleYear
Analysis of the genomic sequences and metabolites of Serratia surfactantfaciens sp. nov. YD25
    BMC genomics, 2016, 11-03, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Computational Biology; Data Mining; Fatty Acids; Genome, Bacterial; Genomics; Lipoproteins; Metabolome; Metabolomics; Multigene Family; Peptides, Cyclic; Phenotype; Phylogeny; Prodigiosin; Quorum Sensing; Serratia

2016
Broad-spectrum antimicrobial activity of secondary metabolites produced by Serratia marcescens strains.
    Microbiological research, 2019, Volume: 229

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Depsipeptides; Lipoproteins; Methicillin-Resistant Staphylococcus aureus; Peptides, Cyclic; Prodigiosin; Pseudomonas aeruginosa; Secondary Metabolism; Serratia marcescens; Surface-Active Agents

2019